Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for improvement of liver function in liver injury
IRCT20080901001165N69Phase 3Completed
- Sponsor
- Bonyan Salamat Kasra
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatic disease comparing L-carnitine with Placebo (2 arms). Primary endpoints: Change in serum ALT and Change in serum AST. Started Sep 2022; status: completed.
02
Drugs
levocarnitine
03
Conditions
hepatic disease
Beyond the preview
Go deeper on IRCT20080901001165N69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001165N69.